Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1993 May;67(5):1053–1057. doi: 10.1038/bjc.1993.193

Melanocytic naevi and melanoma in survivors of childhood cancer.

A Green 1, P Smith 1, W McWhirter 1, P O'Regan 1, D Battistutta 1, M E Yarker 1, K Lape 1
PMCID: PMC1968436  PMID: 8494698

Abstract

There is evidence from previous studies of small numbers of children who received cytotoxic therapy for cancer, that they may develop increased numbers of melanocytic naevi (moles), the strongest known risk factors for melanoma. Our aim was to investigate a large number of survivors of childhood cancer in order to test the hypothesis that they have more melanocytic naevi than matched controls. Total-body naevus counts were obtained from 263 oncology patients ascertained in paediatric oncology departments in Queensland, Australia, and from 263 hospital controls matched for age and sex. Additional information was gathered from children's parents about concurrent factors influencing naevus development such as type of complexion and history of sun exposure. Matched analyses, both crude and adjusted for possible confounding factors, revealed no significant difference in overall density of naevi among oncology patients and control subjects, according to diagnosis or to duration or type of chemotherapy. However significantly more oncology patients had atypical naevi (P < 0.05) and acral naevi (P < 0.0001) than controls. One patient developed a malignant melanoma 13 years after chemotherapy and radiotherapy for rhabdomyosarcoma. These findings support an association between treatment for childhood cancer and acral naevi and suggest that atypical naevi may also be associated with chemotherapy in childhood.

Full text

PDF
1053

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baird E. A., McHenry P. M., MacKie R. M. Effect of maintenance chemotherapy in childhood on numbers of melanocytic naevi. BMJ. 1992 Oct 3;305(6857):799–801. doi: 10.1136/bmj.305.6857.799. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Barker J. N., MacDonald D. M. Eruptive dysplastic naevi following renal transplantation. Clin Exp Dermatol. 1988 Mar;13(2):123–125. doi: 10.1111/j.1365-2230.1988.tb00676.x. [DOI] [PubMed] [Google Scholar]
  3. Gallagher R. P., McLean D. I., Yang C. P., Coldman A. J., Silver H. K., Spinelli J. J., Beagrie M. Suntan, sunburn, and pigmentation factors and the frequency of acquired melanocytic nevi in children. Similarities to melanoma: the Vancouver Mole Study. Arch Dermatol. 1990 Jun;126(6):770–776. [PubMed] [Google Scholar]
  4. Gallais V., Lacour J. P., Perrin C., Ghanem G., Bodokh I., Ortonne J. P. Acral hyperpigmented macules and longitudinal melanonychia in AIDS patients. Br J Dermatol. 1992 Apr;126(4):387–391. doi: 10.1111/j.1365-2133.1992.tb00686.x. [DOI] [PubMed] [Google Scholar]
  5. Green A., Siskind V., Hansen M. E., Hanson L., Leech P. Melanocytic nevi in schoolchildren in Queensland. J Am Acad Dermatol. 1989 Jun;20(6):1054–1060. doi: 10.1016/s0190-9622(89)70131-6. [DOI] [PubMed] [Google Scholar]
  6. Green A., Sorahan T., Pope D., Siskind V., Hansen M., Hanson L., Leech P., Ball P. M., Grimley R. P. Moles in Australian and British school children. Lancet. 1988 Dec 24;2(8626-8627):1497–1497. doi: 10.1016/s0140-6736(88)90980-4. [DOI] [PubMed] [Google Scholar]
  7. Green A., Swerdlow A. J. Epidemiology of melanocytic nevi. Epidemiol Rev. 1989;11:204–221. doi: 10.1093/oxfordjournals.epirev.a036037. [DOI] [PubMed] [Google Scholar]
  8. Heyne K., Hof M., Hansen H. G. Pigmented naevi after therapy of leukaemia (ALL) in a monozygotic twin. Eur J Pediatr. 1984 Apr;142(1):70–70. doi: 10.1007/BF00442597. [DOI] [PubMed] [Google Scholar]
  9. Hughes B. R., Cunliffe W. J., Bailey C. C. Excess benign melanocytic naevi after chemotherapy for malignancy in childhood. BMJ. 1989 Jul 8;299(6691):88–91. doi: 10.1136/bmj.299.6691.88. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Hughes B., Bailey C. C. Excess benign melanocytic naevi. BMJ. 1989 Sep 30;299(6703):854–855. doi: 10.1136/bmj.299.6703.854-d. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Lewis M. G., Johnson K. The incidence and distribution of pigmented naevi in Ugandan Africans. Br J Dermatol. 1968 Jun;80(6):362–366. doi: 10.1111/j.1365-2133.1968.tb12321.x. [DOI] [PubMed] [Google Scholar]
  12. MacKie R. M., English J., Aitchison T. C., Fitzsimons C. P., Wilson P. The number and distribution of benign pigmented moles (melanocytic naevi) in a healthy British population. Br J Dermatol. 1985 Aug;113(2):167–174. doi: 10.1111/j.1365-2133.1985.tb02060.x. [DOI] [PubMed] [Google Scholar]
  13. MacKie R., Hunter J. A., Aitchison T. C., Hole D., Mclaren K., Rankin R., Blessing K., Evans A. T., Hutcheon A. W., Jones D. H. Cutaneous malignant melanoma, Scotland, 1979-89. The Scottish Melanoma Group. Lancet. 1992 Apr 18;339(8799):971–975. doi: 10.1016/0140-6736(92)91539-k. [DOI] [PubMed] [Google Scholar]
  14. MacLennan R., Green A. C., McLeod G. R., Martin N. G. Increasing incidence of cutaneous melanoma in Queensland, Australia. J Natl Cancer Inst. 1992 Sep 16;84(18):1427–1432. doi: 10.1093/jnci/84.18.1427. [DOI] [PubMed] [Google Scholar]
  15. Mosteller R. D. Simplified calculation of body-surface area. N Engl J Med. 1987 Oct 22;317(17):1098–1098. doi: 10.1056/NEJM198710223171717. [DOI] [PubMed] [Google Scholar]
  16. Ochs J., Mulhern R. K. Late effects of antileukemic treatment. Pediatr Clin North Am. 1988 Aug;35(4):815–833. doi: 10.1016/s0031-3955(16)36511-7. [DOI] [PubMed] [Google Scholar]
  17. Streilein J. W. Immunogenetic factors in skin cancer. N Engl J Med. 1991 Sep 19;325(12):884–887. doi: 10.1056/NEJM199109193251210. [DOI] [PubMed] [Google Scholar]
  18. Unreviewed reports. Br Med J (Clin Res Ed) 1984 Sep 22;289(6447):734–734. [PMC free article] [PubMed] [Google Scholar]
  19. de Wit P. E., de Vaan G. A., de Boo T. M., Lemmens W. A., Rampen F. H. Prevalence of naevocytic naevi after chemotherapy for childhood cancer. Med Pediatr Oncol. 1990;18(4):336–338. doi: 10.1002/mpo.2950180417. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES